The Health Science Center at UT Tyler refers to the health science education branch of the University of Texas at Tyler academic campus on U.S. Highway 271. UT Tyler HSC was chartered in 1977 by the University of Texas System Board of Regents. UTHSCT is the only academic medical centre in Northeast Texas.

During the past decade, University of Texas Health Center at Tyler conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Texas Health Center at Tyler" #1 sponsor was "Grifols Therapeutics LLC" with 4 trials, followed by "NSABP Foundation Inc" with 3 trials sponsored, "Sanofi" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Alliance for Clinical Trials in Oncology" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Texas Health Center at Tyler" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Cystic Fibrosis Foundation" with 2 trials as a collaborator, "University of Washington" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Texas Health Center at Tyler" are "Alpha 1-Antitrypsin Deficiency" (3 trials), "Breast Cancer" (3 trials), "Asthma" (2 trials), "Cystic Fibrosis" (2 trials) and "Pulmonary Embolism" (2 trials). Many other conditions were trialed in "University of Texas Health Center at Tyler" in a lesser frequency.

Most popular intervention types in "University of Texas Health Center at Tyler" are "Drug" (19 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alpha-1 MP" (3 trials), "Placebo" (2 trials), "alpha-1 proteinase inhibitor (human)" (2 trials), "cyclophosphamide" (2 trials) and "(LMW)heparin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Texas Health Center at Tyler" are 19 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "University of Texas Health Center at Tyler". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in University of Texas Health Center at Tyler, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Texas Health Center at Tyler, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".